RRD International announced the launch of its new brand, RRD Biopharma Development, representing its unique offering of strategy-driven product development services for biopharmaceutical companies and investors .

The rebrand also includes a new, updated website showcasing the innovative Product Development Team (PDT) model. The PDT model enables biopharmaceutical companies with limited infrastructure to overcome drug development challenges efficiently and effectively to achieve predictable product development results.

RRD's high-caliber team works with companies worldwide, leveraging its unique experience to accelerate drug development and reduce risk. By investing in the success of the assets, the company improves value and increases benefits for patients.

Founded in 2002, the company is part of the Uniphar Group, an international, diversified healthcare services company based in Dublin , Ireland. RRD's asset-centric development approach has helped generate over $3.0 billion in value for its partners over the past 21 years.

Commenting on the rebranding, Scott Tarrant , CEO at RRD Biopharma Development, said: “Our unique approach leverages insights and experiences to strategically plan, optimize and execute biopharmaceutical development, maximize asset value and increase patient access to new products to speed up medication.

Our new, dynamic brand reflects our development offering and underlines the value we provide our partners every day.

The improved branding better communicates who we are and what we do, ultimately supporting our growth and making us a recognized development partner in the market," said Tarrant.